The boss of British drugmaker GlaxoSmithKline has said a "shameful" corruption scandal in China will inevitably impact its business, but he could not yet say by how much.

Andrew Witty spoke as Glaxo unveiled quarterly figures that were marginally better than the market had expected with worldwide sales up by a modest two percent.

...
http://www.euronews.net/